Is BHSRX or MRK a better dividend investment in 2026?

BHSRX currently yields 11.44% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: BHSRX offers higher current income.

What is the dividend yield difference between BHSRX and MRK?

BHSRX has a forward dividend yield of 11.44% ($6.76/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 8.19 percentage points.

Home › Compare › BHSRX vs MRK

BHSRX vs MRK: Dividend Comparison 2026

BHSRX yields 11.44% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BHSRX wins by $11.8K in total portfolio value

INVESTMENT

TIME HORIZON10 years

BHSRX

● Live price

11.44%

Share price

$59.11

Annual div

$6.76

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$42.6K

Annual income

$2,338.57

Full BHSRX calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — BHSRX vs MRK

📍 BHSRX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BHSRX	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BHSRX + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BHSRX pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BHSRX

Annual income on $10K today (after 15% tax)

$972.24/yr

After 10yr DRIP, annual income (after tax)

$1,987.78/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, BHSRX beats the other by $1,180.04/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BHSRX + MRK for your $10,000?

BHSRX: 50%MRK: 50%

100% MRK50/50100% BHSRX

Portfolio after 10yr

$36.7K

Annual income

$1,644.44/yr

Blended yield

4.49%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BHSRX

No analyst data

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BHSRX buys

MRK buys

No recent congressional trades found for BHSRX or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBHSRXMRK

Forward yield	11.44% ✓	3.25%
Annual dividend / share	$6.76 ✓	$3.08
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$42.6K ✓	$30.7K
Annual income after 10y	$2,338.57 ✓	$950.29
Total dividends collected	$17.3K ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: BHSRX vs MRK ($10,000, DRIP)

Year	BHSRX Portfolio	BHSRX Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$11,844	$1,143.81	$11,192	$351.54	+$652.00 → BHSRX
2	$13,939	$1,266.08	$12,524	$392.70	+$1.4K → BHSRX
3	$16,307	$1,392.57	$14,015	$438.65	+$2.3K → BHSRX
4	$18,971	$1,522.59	$15,682	$489.96	+$3.3K → BHSRX
5	$21,955	$1,655.46	$17,547	$547.23	+$4.4K → BHSRX
6	$25,282	$1,790.46	$19,632	$611.16	+$5.7K → BHSRX
7	$28,979	$1,926.93	$21,963	$682.53	+$7.0K → BHSRX
8	$33,071	$2,064.18	$24,571	$762.18	+$8.5K → BHSRX
9	$37,588	$2,201.60	$27,486	$851.08	+$10.1K → BHSRX
10	$42,558	$2,338.57	$30,745	$950.29	+$11.8K → BHSRX

BHSRX vs MRK: Complete Analysis 2026

BHSRX — Stock

The fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It will concentrate its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries.

Full BHSRX Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this BHSRX vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BHSRX vs SCHD BHSRX vs JEPI BHSRX vs O BHSRX vs KO BHSRX vs MAIN BHSRX vs JNJ BHSRX vs ABBV BHSRX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.